Co-Founder, Co-Director, Chair, Distinguished Professor | Birmingham, Alabama
Speaks about :
Pediatrics Infectious Disease, Microbiology, Herpes Simplex Virus, Cytomegalovirus, Antiviral Drugs, Viral Diseases, Herpesvirus Infections
Dr. Richard Whitley is responsible for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group whose role is to perform clinical trials of antiviral therapies directed against medically important viral diseases of children and adults including viruses considered as threats to human health. Whitley’s other research interest is in the translation of molecular biology to clinical application, particularly in the development of human monoclonal antibodies for the therapy of herpesvirus infections and the engineering of the herpes simplex virus for gene therapy. In these latter studies, he and his colleagues have engineered the herpes simplex virus to serve as a vector for foreign gene expression. He received his B.A. in chemistry from Duke University and his M.D. from George Washington University. He subsequently completed an internship in pediatrics and a fellowship in infectious diseases/virology at UAB. He has published more than 380 articles. He participates in numerous Data Safety and Monitoring Boards for ongoing clinical studies. He is a past President of the Infectious Diseases Society of America (IDSA) and received the UAB President’s Medal in 2007. In 2013, he was named the inaugural recipient of the Distinguished Clinical Research Scholar and Educator in Residence at the NIH Clinical Center. He has received numerous other awards and lectureships, including the 2016 UAB SOM Dean’s Excellence Award in Research for Senior Faculty, the Department of Pediatrics Lifetime Achievement Award in Pediatric Healthcare in 2016, and the Honorary Fellowship of the Royal College of Physicians of Ireland, Irish Academy of Medicine in 2018. Dr. Whitley received the Alexander Fleming Award for Lifetime Achievement from the Infectious Diseases Society at their annual meeting in 2018. He received the 2020 National Foundation for Infectious Diseases John P. Utz Leadership Award for his work in the field of clinical virology in December 2020 and is currently the chair of the NIH-NIAID COVID-19 Data Safety and Monitoring Board. He is a Distinguished Professor of Pediatrics, Professor of Microbiology, Medicine and Neurosurgery; Loeb Eminent Scholar Chair in Pediatrics; Co-Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Scientist, Cancer Research and Training Center; Faculty, Gene Therapy Center; Associate Director for Drug Discovery and Development and Senior Leader, Pediatric Oncology Program, O’Neal Comprehensive Cancer Center at UAB; and Co-Founder and Co-Director, Alabama Drug Discovery Alliance.